Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
AXIM Biotechnologies (OTC:AXIM), developers of cannabinoid-based pharmaceutical and cosmetic products, announced the production of CanChew Plus.
CanChew Plus is an upgrade from AXIM's original CanChew, which the company calls "the most well-known cannabis gum product on the market." While the fate of recreational marijuana use has come into question, marijuana stocks as a whole have been on a high in 2017.
Features of CanChew Plus, which is currently in a clinical trial in the Netherlands for the treatment of irritable bowel syndrome, include:
- Non-habit forming
- No prescription needed
- Available in all 50 states
- Comes in a delicious new spearmint flavor
- Great-tasting mint gum has no artificial sweeteners or preservatives
- Non-GMO, gluten free, vegan and kosher
In a press release, AXIM says CanChew Plus contains the same active ingredients and is designed to be 60% smaller than the original CanChew.
Shares of AXIM were down 5.64 percent Wednesday.
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!